Gastrointestinal: Acute pancreatitis, hemorrhagic and necrotizing pancreatitis sometimes resulting in death, ileus General Disorders and Administration Site Conditions: Allergic reactions: rash and pruritus Hepatobiliary: Elevations of liver enzymes, hyperbilirubinemia, cholestasis, cholecystitis, cholelithiasis requiring cholecystectomy, hepatitis Immune system: Angioedema and anaphylactic reactions Metabolism and nutrition: Dehydration resulting from nausea, vomiting and diarrhea Neoplasms: Medullary thyroid carcinoma Nervous system: Dysgeusia, dizziness Pulmonary: Pulmonary aspiration has occurred in patients receiving GLP-1 receptor agonists undergoing elective surgeries or procedures requiring general anesthesia or deep sedation
For optimal results, combine both approaches
Step-by-step programs that equip you with a science-based nutrition and training program that'll help you look better in record-breaking time
Faust, H
The Willow X post doesnt mention that the companys compounded GLP-1 injections and GLP-1 drops, which purportedly contain the same active ingredients in several FDA-approved GLP-1 drugs, specifically, semaglutide and tirzepatide, have not themselves been approved by the FDA
This means: Starting doses are conservative and intentional Adjustments are made based on individual progress The focus remains on long-term metabolic health, not rapid weight loss alone This approach reduces the risk of burnout, both physically and mentally, and helps patients stay consistent
